Our latest research and evaluations is published regularly in:
- 28 February 2014
Magnesium, a treatment for leg cramps?
Quinine was once standard for leg cramps but has proved to have too many adverse effects. Is magnesium an option for patients with leg cramps?
- 6 November 2013
COPD and antibiotics
Chronic obstructive pulmonary disease is a long-term lung disorder that puts patients at risk of complications from colds and flu. Antibiotics may be appropriate for these patients, even for viral infections. Find out more.
- 31 October 2013
Keep taking your statins: benefits outweigh risks
Research shows that the benefits of statins outweigh the risks: people should keep taking their statin medicines, unless their doctor says otherwise. Read more on the risks and benefits of statins.
- 16 October 2013
What you need to know about fixed-dose combinations
What is the evidence surrounding the place in therapy of fixed-dose combination medicines and their harms and benefits?
- 14 August 2013
Stopping smoking: what works for your patients?
A meta-analysis of pharmacological interventions for smoking cessation (nicotine replacement therapy, varenicline & bupropion) - some treatments better than others.
Contact our media team
If you are a journalist seeking comment on a story or more information on any of our programs or campaigns please contact the NPS MedicineWise media team
on 02 8217 8667.
For urgent media requests outside of office hours, please call 0419 618 365. If your request is not urgent you can also email an enquiry.
Publications & Programs
Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for health professionals.
Peak stories have included the top 10 most expensive drugs, eradication of Hepatitis C, drug seeking behaviours in people and more.
RADAR provides health professionals with timely information on new drugs, medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
Peak stories have included warfarin, campaigns urging doctors to seeing health reps, and treating Hepatitis C.